Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells
(Q28301485)
scientific article
scientific article
Language:
| (P31) |
(Q13442814)
|
||||||||||||||||
| (P304) |
1682-7
|
||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||
| (P433) |
3
|
||||||||||||||||
| (P478) |
272
|
||||||||||||||||
| (P577) |
Friday, January 17, 1997
|
||||||||||||||||
| (P921) |
(Q643839)
(Q412178) (Q898365)
(Q424213)
(Q410291)
(Q367700)
|
||||||||||||||||
| (P1433) |
(Q867727)
|
||||||||||||||||
| (P1476) |
"Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells" (language: en)
|
||||||||||||||||
| (P2093) |
Y Lavie
H t Cao
A Volner
A Lucci
T Y Han
V Geffen
A E Giuliano
M C Cabot
|